Cite
HARVARD Citation
Tryggestad, A. et al. (2022). Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy. Prostate. 82 (2), pp. 245-253. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tryggestad, A. et al. (2022). Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy. Prostate. 82 (2), pp. 245-253. [Online].